Clinical analysis of candidemia in immunocompetent patients.
- Author:
Yan Ling DING
1
;
Ning SHEN
1
;
Qing Tao ZHOU
1
;
Bei HE
1
;
Jia Jia ZHENG
2
;
Xin Mao ZHAO
3
Author Information
1. Department of Respiratory Medicine, Peking University Third Hospital, Beijing 100191, China.
2. Department of Laboratory Medicine, Peking University Third Hospital, Beijing 100191, China.
3. Department of Nosocomial Infection,Peking University Third Hospital, Beijing 100191, China.
- Publication Type:Journal Article
- MeSH:
APACHE;
Adolescent;
Adult;
Aged;
Aged, 80 and over;
Candida;
Candidemia/therapy*;
Candidiasis/therapy*;
Female;
Humans;
Immunocompetence;
Intensive Care Units;
Male;
Middle Aged;
Retrospective Studies;
Risk Factors;
Young Adult
- From:
Journal of Peking University(Health Sciences)
2018;50(6):1063-1069
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the etiological and clinical characteristics of immunocompetent patients with candidemia.
METHODS:The clinical and microbiological data of patients diagnosed as candidemia admitted in Peking University Third Hospital from January 2010 to June 2016 were retrospectively analyzed. Underlying diseases, Candida spp. colonization, clinical manifestations, microbiological data, treatment and the outcome were compared between the HIV-negative immunocompromised (IC) and nonimmunocompromised (NIC) patients.
RESULTS:A total of 62 cases diagnosed as candidemia were analyzed including 36 men and 26 women, with 16 to 100 years of age [(66.02±17.65) years]. There were 30 NIC and 32 HIV-negative IC patients respectively. In the NIC patients, there were 19 cases (19/30, 63.33%) with admission in intensive care unit (ICU), 21 (21/30, 70.00%) associated diabetes mellitus or uncontrolled hyperglycemia and 22 (22/30,73.33%) receiving invasive mechanical ventilation, while in the HIV-negative IC patients, there were 8 (8/32, 25.00%), 13 (13/32, 40.63%) and 7 (7/32, 21.88%) respectively (P<0.05). The NIC patients had higher acute physiology and chronic health evaluation (APACHE II) scores and sequential organ failure assessment (SOFA) scores both at admission (19.98±5.81, 6.04±6.14) and candidemia onset (25.61±6.52, 12.75±8.42) than the HIV-negative IC patients (APACHEII 15.09±5.82, 22.15±5.98) and SOFA 2.87±2.73, 7.66±5.64 respectively (P<0.05). In the NIC patients, twenty-one cases (21/30, 70.00%) died in hospital, while 14 cases (14/32, 43.75%) in HIV-negative IC. The crude mortality was significantly different between the two groups (P<0.05). By blood culture, Canidia albicans remained the the most prevalent isolates in all the patients. Clinical manifestation, Candida spp. colonization, etiology and drug susceptibility were also similar between NIC and HIV-negative IC patients (P>0.05).
CONCLUSION:Candidemia in NIC patients tends to occur in those who are much more critically ill, more often admitted in ICU, and more frequently have diabetes mellitus or uncontrolled hyperglycemia and receive invasive mechanical ventilation than HIV-negative IC patients. NIC patients also have poorer prognosis than HIV-negative IC patients. Clinical manifestations, and microbiological characteristics are similar between HIV-negative IC and NIC patients.
